Poolbeg Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of POLB.F?
Owner Type	Number of Shares	Ownership Percentage
Employee Share Scheme	379,708	0.0539%
Public Companies	7,883,466	1.12%
Private Companies	57,889,257	8.21%
General Public	104,998,001	14.9%
Individual Insiders	113,318,665	16.1%
Institutions	420,634,681	59.7%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 41%.

Top Shareholders

Top 25 shareholders own 70.32% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
11.2%	Hargreaves Lansdown Asset Management Ltd.	78,727,947	US$4.5m	-3.16%	0.01%
6.14%	Michael Kelly	43,314,547	US$2.5m	4.51%	no data
5.92%	Aberdeen Group Plc	41,772,894	US$2.4m	13.1%	no data
5.67%	Roaring Waters Capital Limited	40,000,000	US$2.3m	0%	no data
4.73%	Platform Capital Holdings Ltd	33,318,362	US$1.9m	0%	1.32%
3.83%	Allan Rankin	27,016,038	US$1.5m	0%	no data
3.61%	HBOS Investment Fund Managers Limited	25,470,421	US$1.4m	-0.04%	0.01%
3.54%	Cathal Friel	24,964,193	US$1.4m	0%	no data
2.64%	AIB Group plc	18,592,732	US$1.1m	-0.1%	0.64%
2.16%	GHC Capital Markets Ltd.	15,256,376	US$867.0k	0%	0.81%
2.09%	Raglan Road Capital Limited	14,702,633	US$835.6k	0%	31.18%
2.02%	Citigroup Inc.	14,212,092	US$807.7k	0%	no data
1.9%	IG Group Holdings plc	13,403,844	US$761.7k	-13.9%	0.05%
1.77%	Barclays Bank PLC	12,450,914	US$707.6k	4.68%	no data
1.76%	TrinityBridge Limited	12,420,937	US$705.9k	0.59%	no data
1.62%	Hedley & Company Stockbrokers Ltd.	11,447,454	US$650.6k	0%	0.35%
1.56%	Seneca Partners Limited	11,006,157	US$625.5k	0%	14.39%
1.39%	Dolmen Fund Management	9,822,464	US$558.2k	-5.71%	0.19%
1.22%	Dominion Fiduciary Services Limited	8,597,794	US$488.6k	0%	100.0%
1.19%	DEGIRO B.V.	8,360,503	US$475.1k	7.49%	0.06%
1.18%	Ian O'Connell	8,326,839	US$473.2k	0%	no data
0.88%	Patrick Reid	6,192,077	US$351.9k	0%	no data
0.85%	Deutsche Bank Aktiengesellschaft	6,000,000	US$341.0k	0%	no data
0.76%	Patronus Partners Limited	5,387,069	US$306.1k	7.88%	1.03%
0.72%	Sterling Investments Management Limited	5,042,590	US$286.6k	0%	1.22%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/03/18 03:11
End of Day Share Price	2026/03/10 00:00
Earnings	2025/06/30
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Poolbeg Pharma PLC is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Adam McCarter	Cavendish
Brian White	Shore Capital Group Ltd